NeutralMEDIUM severityEarnings7d ago

Claritev GAAP EPS of -$3.64 misses by $0.01, revenue of $268.3M beats by $12.17M

Claritev GAAP EPS of -$3.64 misses by $0.01, revenue of $268.3M beats by $12.17M — $CTEV one-month chart
$CTEV daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOK’s read

Claritev shares jumped 5.68% to $24.00, near the lower end of its 52-week range. The stock is trading at 20% of its full range, from $11.50 to $72.67, with most recent coverage concentrated in the last week and mostly neutral. The Health Care sector shows calm today.

Written by Wook AI Nov 9, 10:15 PM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about CTEV. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · claritevEvent risk Low

Nothing reported about claritev across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 106% a year
Now $24.99Week $21.24–$28.74 (±15.0%)Month $17.31–$32.67 (±30.7%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: The headline zeroes in on one number — but the real story lies in the trend, not the snapshot. A single data point can't tell you where the company is headed.
  • How the stock is trading: $CTEV -6.82% in the latest session.
  • Timing: It came out pre-market, so the next session was the first that could react.
Amount$3.64
Amount$0.01
Amount$268.3 million
Amount$12.17 million

Where the stock stands

Claritev ($CTEV) fell 6.82% to $24.99 in the latest session. Over the past month it is up 13.8%. It now sits 55% under the 52-week high of $55.50 and 117% above the year's low of $11.50. The year's high was 4.8 times its low, which makes double-digit swings fairly routine here.

How much coverage it is getting

This is one of 2 stories on Claritev in Wook's last 30 days of coverage, including 0 this week. None came this week, so coverage has gone quiet. Going by their wording, 0 read bullish, 2 neutral and 0 bearish. This one reads neutral, like most of them. 2 came from Seeking Alpha and the rest from other outlets, so more than one newsroom is on it.

The bigger picture

Earnings aren't just about the numbers — they're about how they stack up against expectations and what the company says about the road ahead. A beat with poor guidance can feel like a miss. Wook's supply-chain scanner shows no unusual stress in Health Care today.

What to watch next

The $CTEV page has the full chart, filings, and models to dig into. Reading another outlet can help confirm or reveal if the story is being repeated. Wook AI is here to help with the math — where $CTEV stands and how this coverage fits in.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on November 9, 2026. $CTEV has moved +3.69% ($24.10 to $24.99). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy